Skip to content

Posaconazole

Noxafil (posaconazole) is a small molecule pharmaceutical. Posaconazole was first approved as Noxafil on 2005-10-25. It is used to treat mycoses and oral candidiasis in the USA. It has been approved in Europe to treat aspergillosis, candidiasis, coccidioidomycosis, and mycoses. Noxafil's patents are valid until 2033-02-27 (FDA).
Trade Name Noxafil
Common Name Posaconazole
Indication aspergillosis, candidiasis, coccidioidomycosis, mycoses, oral candidiasis
Drug Class Systemic antifungals (miconazole type)
Posaconazole
Get full access now